🇺🇸 FDA
Patent

US 10000746

LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof

granted A61KA61K38/465A61K48/00

Quick answer

US patent 10000746 (LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof) held by PRECISION GENOME ENGINEERING, INC. expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRECISION GENOME ENGINEERING, INC.
Grant date
Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/465, A61K48/00, A61P, A61P35/00